Retatrutide side effects: separating TikTok anecdotes from trial data

What did @ursulah6335 actually say?

She said she has been using retatrutide for two weeks and that over the last three days she has developed nausea, brain fog, joint aches, and shaking so severe she had to leave work. She is genuinely unsure whether she is sick, got a bad batch, or her body simply does not tolerate the drug. This is not a promotional video. It is a distress call from someone with no apparent health literacy background asking strangers on TikTok for medical guidance.

To be clear: she is not making health claims. She is describing symptoms and asking for help. That framing matters for how we evaluate the content, because the risk here is not misinformation from the creator. It is misinformation flowing back to her in the comments.

Does the science back this up?

Yes, largely. Nausea and gastrointestinal distress are the most consistently reported side effects of triple agonist GLP-1/GIP/glucagon receptor drugs, and retatrutide fits that profile. The joint aches and brain fog are less well-documented but not implausible.

Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. In the Phase 2 trial published by Jastreboff et al. (2023, New England Journal of Medicine), nausea was reported in 45 to 67 percent of participants depending on dose, and vomiting in 20 to 30 percent. These numbers are higher than what is seen with semaglutide or tirzepatide. The trial also noted that most GI side effects peaked in the first several weeks and were dose-dependent. Retatrutide is not FDA-approved. There are no approved human formulations. Any product someone is currently using is either compounded or from a gray-market research chemical supplier, which introduces real batch-quality variables she is right to consider.

What did they get wrong (or right)?

She got more right than wrong, honestly. Her instinct to ask whether she has a "bad batch" is clinically reasonable, not paranoid. Compounded peptides are not subject to the same quality controls as FDA-approved drugs, and contamination or incorrect concentration is a genuine documented risk with compounded GLP-1 class drugs. The FDA issued warnings about compounded semaglutide products specifically around dosing errors and contamination in 2023 and 2024.

Where her framing gets murky is the phrase "my body doesn't respond to the Retta well." Non-response in the clinical sense means the drug is not producing its intended effect. What she is actually describing is the opposite: her body may be responding strongly, producing pronounced side effects at a dose that is too high or escalated too quickly. That is a meaningful distinction. The shaking she describes is worth flagging separately. Tremor is not a commonly reported effect of GLP-1 class drugs in trials and could indicate dehydration, hypoglycemia, anxiety, or something unrelated to retatrutide entirely.

What should you actually know?

The core issue here is that she is using an unapproved investigational drug with no prescribing physician apparently reachable enough to call when she becomes symptomatic. That is the actual problem, not whether nausea at week two is "normal."

Nausea in the first two to six weeks of a GLP-1 class drug is common and usually dose-related. The standard clinical approach is dose reduction or slower titration, not discontinuation. But that decision requires someone who knows her dose, her medical history, and can rule out other causes. Posting on TikTok is not that. If symptoms include shaking, inability to function, and they have lasted three days, the appropriate step is contact with a prescriber or urgent care, not waiting for comment section consensus. Anyone telling her in the comments to "push through it" or suggesting specific dosing changes is giving her advice that could cause harm.

The bottom line on retatrutide side effects

Retatrutide produces more nausea than older GLP-1 drugs, the Phase 2 data confirms this clearly. Two weeks in, with escalating GI symptoms and systemic effects, is a plausible presentation of dose-related toxicity, a bad compounded batch, illness, or all three at once. The honest answer is that without knowing her source, her dose, her titration schedule, and her baseline health, no one online can tell her which it is. Anyone who claims otherwise in her comments is guessing.